Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review

SW Smail, M Saeed, ZO Khudhur, DA Younus… - Food and Chemical …, 2021 - Elsevier
Abstract Coronavirus disease-19 (COVID-19) is a complex disease that causes illness
ranging from mild to severe respiratory problems. It is caused by a novel coronavirus SARS …

[HTML][HTML] Innate immune response to SARS-CoV-2 infection: From cells to soluble mediators

D Ricci, MP Etna, F Rizzo, S Sandini, M Severa… - International journal of …, 2021 - mdpi.com
The vulnerability of humankind to SARS-CoV-2 in the absence of a pre-existing immunity,
the unpredictability of the infection outcome, and the high transmissibility, broad tissue …

Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies

PM Varghese, AG Tsolaki, H Yasmin, A Shastri… - Immunobiology, 2020 - Elsevier
The current coronavirus pandemic, COVID-19, is the third outbreak of disease caused by the
coronavirus family, after Severe Acute Respiratory Syndrome and Middle East Respiratory …

Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management

AU Anka, MI Tahir, SD Abubakar… - Scandinavian …, 2021 - Wiley Online Library
SARS‐CoV‐2 is a novel human coronavirus responsible for the Coronavirus disease 2019
(COVID‐19) pandemic. Pneumonia and acute respiratory distress syndrome are the major …

[HTML][HTML] COVID-19: imbalanced immune responses and potential immunotherapies

B Xie, J Zhang, Y Li, S Yuan, Y Shang - Frontiers in Immunology, 2021 - frontiersin.org
The ongoing pandemic coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly spreading and has resulted in …

[HTML][HTML] The cytokine storm in COVID-19: the strongest link to morbidity and mortality in the current epidemic

M Basheer, E Saad, N Assy - COVID, 2022 - mdpi.com
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. The clinical
presentations of the SARS-CoV-2 infection are widely variable and treatment strategies for …

[HTML][HTML] COVID-19: A state of art on immunological responses, mutations, and treatment modalities in riposte

X Gong, A Khan, MY Wani, A Ahmad, A Duse - Journal of Infection and …, 2023 - Elsevier
Over the last few years, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
unleashed a global public health catastrophe that had a substantial influence on human …

Chemotherapy vs. Immunotherapy in combating nCOVID19: An update

A Choudhury, G Mukherjee, S Mukherjee - Human Immunology, 2021 - Elsevier
The nCOVID-19 pandemic initiated its course of contagion from the city of Wuhan and now it
has spread all over the globe. SARS-CoV-2 is the causative virus and the infection as well …

Immunomodulation as a potent COVID-19 pharmacotherapy: Past, present and future

DM Hertanto, BS Wiratama, H Sutanto… - Journal of …, 2021 - Taylor & Francis
In the first year of its appearance, the 2019 coronavirus disease (COVID-19) has affected
more than 150 million individuals and killed 3 million people worldwide. The pandemic has …

[HTML][HTML] Unraveling the mystery surrounding post-acute sequelae of COVID-19

RK Ramakrishnan, T Kashour, Q Hamid… - Frontiers in …, 2021 - frontiersin.org
More than one year since its emergence, corona virus disease 2019 (COVID-19) is still
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …